Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Oct;18(4):525–528. doi: 10.1128/aac.18.4.525

Influence of chemical modification of N alpha-cocoyl-L-arginine ethyl ester on its hepatitis B surface antigen-inactivating effect.

Y Sugimoto, S Toyoshima
PMCID: PMC284042  PMID: 7447415

Abstract

We have reported previously that N alpha-cocoyl-L-arginine ethyl ester (CAE) strongly inactivates hepatitis B surface antigen (HBsAg; Sugimoto and Toyoshima, Antimicrob. Agents Chemother. 16:329--332, 1979). Replacement of the L-arginine moiety of CAE by L-lysine did not decrease the HBsAg-inactivating effect of CAE, whereas replacement by some neutral amino acids and L-ornithine decreased it. Esterification of the carboxyl group of N alpha-acyl-L-arginine enhanced its inactivating effect. When the ethyl ester of CAE was converted to an amide group, the effect was appreciably decreased. Modification of the carboxyl group was essential for the inactivation. The effectiveness of N alpha-acyl-L-arginine ethyl ester depends upon the length of the acyl group, with the optimum length for the inactivation of HBsAg being C12 to C14. In addition to CAE, N alpha-lauroyl-L-lysine ethyl ester and N alpha-cocoyl-L-arginine amide were found to be strong inactivators of HBsAg. Significant inactivating effects on HBsAg were not observed in many anionic detergents containing an amino acid. These results suggest that for strongly inactivating HBsAg, a compound should contain a special amino acid, such as L-arginine, and a long acyl group and exhibit a cationic property.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. De Flora S. [Thermal inactivation of hepatitis B surface antigen]. J Immunol. 1978 Jan;120(1):40–45. [PubMed] [Google Scholar]
  2. Horst H., Tripatzis I., Konstantinidis I. Australia-Antigen: Wirkung chemischer und physikalischer Massnahmen auf die Antigenität. Zentralbl Bakteriol Orig A. 1972 Jan;219(1):1–6. [PubMed] [Google Scholar]
  3. Howard C. R., Burrell C. J. Structure and nature of hepatitis B antigen. Prog Med Virol. 1976;22:36–103. [PubMed] [Google Scholar]
  4. Kim C. Y., Bissell D. M. Stability of the lipid and protein of hepatitis-associated (Australia) antigen. J Infect Dis. 1971 May;123(5):470–476. doi: 10.1093/infdis/123.5.470. [DOI] [PubMed] [Google Scholar]
  5. Sugimoto Y., Toyoshima S. N-alpha-Cocoyl-L-arginine ethyl ester, DL-pyroglutamic acid salt, as an inactivator of hepatitis B surface antigen. Antimicrob Agents Chemother. 1979 Sep;16(3):329–332. doi: 10.1128/aac.16.3.329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Takahashi T., Nakagawa S., Hashimoto T., Takahashi K., Imai M. Large-scale isolation of Dane particles from plasma containing hepatitis B antigen and deomnstration of circular double-stranded DNA molecule extruding directly from their cores. J Immunol. 1976 Oct;117(4):1392–1397. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES